Heron's CRL Is Just A Minor Bump And Resubmission For Approval Will Come QuicklySeeking Alpha • 05/08/19
Heron Therapeutics (HRTX) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 05/02/19
Why Heron Therapeutics and Pacira BioSciences Are Moving in Opposite Directions TodayThe Motley Fool • 05/01/19
Heron Therapeutics stock down 31% after FDA says it can't approve pain drug without more infoMarket Watch • 05/01/19